JESSICA MUSGROVE: Open Payments
NPI 1760965008 · FAYETTEVILLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,654 in 176 payments from 12 companies in 2025. Trend: 2023 $1,521 · 2024 $2,165 · 2025 $2,654
Food & beverage: $2,654
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 50 | $625 |
| Alkermes, Inc. | 21 | $266 |
| Supernus Pharmaceuticals, Inc. | 17 | $252 |
| Otsuka America Pharmaceutical, Inc. | 11 | $246 |
| ABBVIE INC. | 19 | $229 |
| Axsome Therapeutics, Inc. | 7 | $214 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $175 |
| Corium, LLC | 10 | $172 |
| Collegium Pharmaceutical, Inc. | 9 | $149 |
| Lundbeck LLC | 10 | $147 |
Products named: CAPLYTA, REXULTI, ARISTADA, VRAYLAR, Auvelity, TRINTELLIX, Azstarys, Jornay PM.
Industry payments across AR — which companies pay providers there.
